Nomi Masashi, Sengoku Atsushi, Krogh Klaus, Emmanuel Anton, Christiansen Albert Bohn
Department of Urology, Hyogo Prefectural Central Rehabilitation Hospital, Hyogo 651-2181, Japan.
Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8000 Aarhus, Denmark.
J Clin Med. 2021 Mar 1;10(5):934. doi: 10.3390/jcm10050934.
Prospective observational study.
To validate the Monitoring Efficacy of NBD Treatment On Response (MENTOR) tool in individuals with a spinal cord injury (SCI) or spina bifida, suffering from neurogenic bowel dysfunction (NBD) in a rehabilitation center in Japan.
First, the MENTOR tool was translated from English to Japanese using a validated translation process. Second, the MENTOR tool was validated in a rehabilitation clinic in Japan. Participants completed the MENTOR tool prior to a consultation with an expert physician. According to the results of the tool, each participant was allocated to one of three categories regarding change in treatment: "adequately treated," "further discussion," and "recommended change." The results of the MENTOR tool were compared with the treatment decision made by an expert physician, who was blinded to the results of the MENTOR tool.
A total of 60 participants completed the MENTOR tool. There was an acceptable concordance between individuals allocated as respectively, being adequately treated (100%) and recommended change in treatment (61%) and the physicians' decision on treatment. The concordance was lower for individuals allocated as requiring further discussion (48%).
In this study the MENTOR tool was successfully validated in a Japanese rehab setting. The tool will help identify individuals with SCI that need further treatment of their NBD symptoms.
前瞻性观察性研究。
在日本一家康复中心,验证神经源性肠功能障碍(NBD)治疗反应监测疗效(MENTOR)工具在脊髓损伤(SCI)或脊柱裂患者中的有效性。
首先,使用经过验证的翻译流程将MENTOR工具从英语翻译成日语。其次,在日本的一家康复诊所对MENTOR工具进行验证。参与者在咨询专家医生之前完成MENTOR工具。根据工具的结果,每位参与者在治疗变化方面被分配到以下三类之一:“治疗充分”、“进一步讨论”和“建议改变”。将MENTOR工具的结果与一位对MENTOR工具结果不知情的专家医生做出的治疗决定进行比较。
共有60名参与者完成了MENTOR工具。在分别被分配为治疗充分(100%)和建议改变治疗(61%)的个体与医生的治疗决定之间,存在可接受的一致性。对于被分配为需要进一步讨论的个体,一致性较低(48%)。
在本研究中,MENTOR工具在日本康复环境中成功得到验证。该工具将有助于识别需要进一步治疗其NBD症状的SCI个体。